Westlake, Texas-based MiddleBrook Pharmaceuticals, Inc. has completed the hiring of its 271-person nationwide field sales force. The 271 territory managers comprising MiddleBrook's field sales force will begin educating healthcare professionals on the benefits of Moxatag (extended-release amoxicillin) tablets, 775 mg—a once-daily amoxicillin that was approved by the FDA on Jan. 23, 2009.
According to Middlebrook officials, MiddleBrook's territories have been structured to maximize the 271-person field sales force's ability to detail healthcare professionals nationwide, including pharmacists. The field force's efforts will be supported by a print media campaign targeted at healthcare professionals.
John Thievon, president and CEO of MiddleBrook said, “MiddleBrook's field sales force will be talking to physicians and pharmacists across the country about the benefits of Moxatag, patient convenience, improved compliance and a lower overall daily dose.”